The largest database of trusted experimental protocols

5 protocols using mouse igg2b isotype control

1

Monocyte Subset Analysis and GLP-1R Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples were collected into K2-EDTA tubes (BD-Plymouth, PL6 7BP, UK) by vein puncture and immediately prepared for FACS analysis. Briefly, blood was treated with human Fc-Receptor blocking solution (Biolegend, San Diego, CA), and subsequently stained with detection antibodies: anti human CD14 (Biogems, Westlake Village, CA); anti human CD16 (Biolegend, San Diego, CA); and either anti GLP-1R or mouse IgG2b isotype control (R&D Systems Minneapolis, MN). After erythrocytes lysis, cells were centrifuged, re-suspended in cold PBS and analyzed by flow cytometer (Navios, Beckman Coulter, Indianapolis, IN) using Flowing Software 2.5.1 (Turku Center for Biotechnology, Finland). Proportions of CD14/CD16 monocyte subsets were determined within the monocyte-enriched population based on forward and side-scatter gating. GLP-1R expression was assessed as the percentage of cells with AlexaFluor 488 signal greater than the isotype control.
+ Open protocol
+ Expand
2

Immunohistochemical Staining of IL-26 and CD68 in BAL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ICC staining was performed using cytospin slides prepared with freshly isolated BAL cells harvested from LTRs. These cytospin samples were air-dried and frozen (− 80 °C) until further processing. For study processing, the cytospin slides were thawed and fixed in formaldehyde (4%). To reduce unspecific staining, the slides were incubated first with protein serum-free block (Dako® Agilent Technologies, Denmark), followed by horse serum (5%), and, subsequently, by BLOXALL (Vector Laboratories® Ca, USA). After this, the slides were incubated with primary monoclonal mouse anti-human IL-26 antibodies (5 ug/ml) (Clone 197505, R&D Systems Inc., Mi, USA) or mouse IgG2b isotype control (Clone 20116, R&D Systems Inc.). After washing, slides were incubated with a secondary antibody from the anti-mouse immPRESS kit (5ug/l) (Vector Laboratories®). Bound antibodies were then visualized by ImmPACT VIP-substrate chromogen system (Vector Laboratories®). The procedure was then repeated with in-between washes, but with a primary rabbit anti-human CD68 antibody (5ug/ml) (Abbiotech® Ca, USA), followed by a secondary antibody from the anti-rabbit immPRESS kit (Vector Laboratories®). Bound antibodies were now visualized by ImmPACT DAB-substrate chromogen system (Vector Laboratories®), and slides were finally counterstained with Methyl Green (Vector Laboratories®).
+ Open protocol
+ Expand
3

KIR3DL3 Expression Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with mouse IgG2B isotype control (R&D Systems, Minneapolis, MI, USA) or primary mouse anti-KIR3DL3 antibody kindly provided by Professor Ashley Moffet, University of Cambridge, UK [16 (link)]. Where necessary, a goat anti-mouse PE secondary antibody was used (R&D Systems, Minneapolis, MI, USA). The level of KIR3DL3 expression was analyzed by the Beckman Coulter Gallios and the Kaluza Flow Analysis Software (Beckman Coulter, Fullerton, CA, USA). Percentage of positive cells and mean fluorescence intensity (MFI) were calculated following consideration of the values from the isotype control.
+ Open protocol
+ Expand
4

Chemokine Expression Analysis in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Circular cover slips (12 mm diameter) were placed in wells of a 24-well tissue culture plate and coated with recombinant human fibronectin for 2 h at 37°C or overnight at 4°C. Cells were grown on these cover slips for 18–20 h in complete vascular cell growth medium at 37°C with 5% CO2. Samples were fixed with paraformaldehyde (4%, Thermo Scientific)) in PBS and 2% sucrose for 30 min at RT. For permeabilization, samples were incubated with 0.1% Triton X-100 for 5 min and after extensive washing, blocked with 2% BSA/PBS for 30 min at RT. Samples were incubated with primary antibodies against chemokines CCL2 (5 μg, MAB679) CCL5 (5 μg, MAB278), CCL7 (5 μg, MAB282), CCL8 (5 μg, MAB281), CCL20 (5μg, AF360), CXCL9 (5 μg, MAB392), mouse IgG1 isotype control (5 μg, MAB002) and mouse IgG2B isotype control (MAB004) all from R&D Systems, at RT for 2 h. Cells were washed three times with PBS before incubating with secondary antibody Alexa Fluor 488 (1:500, A-11017; Invitrogen) for 1 h and after washing three times with PBS, were counter-stained with DAPI (1μg/ml 62248; Invitrogen). Images were captured using a Leica SP8 (690) fluorescence microscope. Images were obtained with 40x objective. Images were analyzed using IMARIS software (Oxford Instruments).
+ Open protocol
+ Expand
5

Labeling Proteins in Mesothelioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
REN cells (human mesothelioma) were grown to confluence in RPMI 1640 medium with 10% fetal bovine serum supplemented with 2 mM l-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin (Life Technologies, Carlsbad, CA). T7 Express Crystal Competent E. coli (C3022I) was purchased from New England Biolabs (Ipswich, MA). 4-Azido-l-phenylalanine (sc-289923A) was purchased from Santa Cruz Biotechnology Inc. (Dallas, TX). EDTA-Free SIGMAFAST Protease Inhibitor Cocktail Tablets (S8830), dibenzocyclooctyne-N-hydroxysuccinimidyl ester (761524) were purchased from Sigma-Aldrich (St. Louis, MO). Click-IT Alexa Fluor 488 DBCO (C10405) and Alexafluor750 Succinimidyl Ester (A20011) were purchased from ThermoFisher Scientific (Waltham, MA). Iodogen was purchased from Pierce Biotechnology (Rockford, IL). Radioactive isotope 125I was purchased from PerkinElmer (Wellesley, MA). 111InCl3 was purchased from Nuclear Diagnostic Products (Cherry Hill, NJ). Mouse IgG2B Isotype Control was from R&D Systems, Inc. (Minneapolis, MN). Antimouse-ICAM-1 mAb (clone YN1/1.7.4) was produced by the hybridoma technology66 (link)–69 and purified using protein G Sepharose from GE Healthcare Biosciences (Pittsburgh, PA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!